COVID19 vaccine in myasthenia gravis patients: safety and possible predictors of disease exacerbation

Neurol Sci. 2023 Feb;44(2):447-450. doi: 10.1007/s10072-022-06584-w. Epub 2022 Dec 25.
No abstract available

Publication types

  • Letter

MeSH terms

  • COVID-19 Vaccines* / adverse effects
  • COVID-19* / prevention & control
  • Disease Progression
  • Humans
  • Myasthenia Gravis* / complications

Substances

  • COVID-19 Vaccines